Your browser doesn't support javascript.
loading
Hypertrophic Lupus Erythematosus Successfully Treated with Triamcinolone Intralesional Injection / 대한피부과학회지
Korean Journal of Dermatology ; : 1132-1135, 2010.
Article in Ko | WPRIM | ID: wpr-23193
Responsible library: WPRO
ABSTRACT
Hypertrophic lupus erythematosus (HLE) is a distinct and rare clinical variant of chronic cutaneous lupus erythematosus (CCLE). It is characterized by verrucous lesions and a chronic course of disease. HLE tends to be much more refractory to treatment than classical CCLE. Therefore, the traditionally available therapeutic options including sun protection, topical and oral corticosteroids, hydroxychloroquine, retinoid and thalidomide are often unable to control the disease. We report here on the successful use of triamcinolone intralesional injection in a patient with HLE and who failed to respond to conventional treatment such as acitretin and hydroxychloroquine.
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Thalidomide / Lupus Erythematosus, Cutaneous / Triamcinolone / Injections, Intralesional / Solar System / Adrenal Cortex Hormones / Acitretin / Hydroxychloroquine Limits: Humans Language: Ko Journal: Korean Journal of Dermatology Year: 2010 Type: Article
Full text: 1 Index: WPRIM Main subject: Thalidomide / Lupus Erythematosus, Cutaneous / Triamcinolone / Injections, Intralesional / Solar System / Adrenal Cortex Hormones / Acitretin / Hydroxychloroquine Limits: Humans Language: Ko Journal: Korean Journal of Dermatology Year: 2010 Type: Article